Agenda

CONFERENCE DAY 1
Tuesday, 29 October 2019
CONFERENCE DAY 2
Wednesday, 30 October 2019

Registration & Networking Breakfast in Exhibition Hall

Chairpersons’ Opening Remarks

Keynote: Can a Transformational Product Transform Market Adoption?

Every category has certain adoption dynamics driven by the previously recently launched products in the category.

When faced with a new product that can be transformational to the field, the key issue becomes understanding the adoption dynamics, identifying the drivers of change within this dynamic, and then building a plan to deliver on transforming the adoption cycle.

Presented by Axovant Gene Therapies

Keynote: Future of Pharma

Presented by VI Partners

Keynote Panel: Reaction/Response to Keynote Presentations

Presented by Actelion, Boehringer Ingelheim, GlaxoSmithKline, MSD, Teva Pharmaceuticals Europe, and UCB

Networking & Refreshments in Exhibition Hall

“Ask the Experts” Interactive Breakout Round Tables Group 1

ROUND TABLE 1
Overcoming Hurdles in Social Media Listening

Presented by Janssen

ROUND TABLE 2
How to Obtain Maximum Added Value from Collected Information? How Can Dashboards and Databases Help and What Are the Pitfalls to Avoid?

Presented by Roche

ROUND TABLE 3
Patient Centricity

Presented by Ferring Pharmaceuticals

Networking Luncheon

SESSION ONE

Healthcare Megatrends - Examining the Shift to the Next Era of Healthcare

Presented by Lifescience Dynamics

SESSION TWO

TBA

Presented by AplusA

SESSION ONE

Humanizing Analytics

Presented by Takeda

SESSION TWO

Are You a Traditional Market Research Provider or a Partner That Provides Your Company with Competitive Advantage

Often the market insights function is still stuck in a service and delivery mode for data and information.

Let’s reflect and challenge this situation assessing the requirements and changes needed to become a stronger voice with confidence, driving insights to action.

Presented by Lonza

SESSION ONE

Trends in Global Healthcare: Highlights of 2019, and Where We’re Headed

As uncertainty over pricing grows in the US, global pharma companies are reconsidering their geographic prioritizations for development and commercialization.

This session will draw connections between the global economy and healthcare spending across regions, and highlight the characteristics of the companies that are most successful in international markets.

Presented by DuckerFrontier

SESSION TWO

TBA

Presented by Cello Health Insight

Presented by Cello Health Insight

Networking & Refreshments in Exhibition Hall

SESSION ONE

Brands and the Decline of Meaning

Brands confer meaning. Apple stands for individuality. Nike stands for participation. Disney stands for magic.

Pharma brands confer meaning, too. But lately, meaning has taken a hit. There’s so much data, so many voices, so many alternative sets of facts. Can we really know or believe anything anymore? And how does this affect brands? This talk looks at how brands have evolved over the past several years, including consumer, B2B, and pharma brands, specifically in psoriasis. In a world where meaning is eroding, are brands losing ground? Or by contrast, more essential than ever? The evidence may surprise you.

Presented by M Health

SESSION TWO

TBA

Presented by Research Partnership

SESSION ONE

How to Do More With Tighter Budgets

Presented by Alnylam, Fresenius Kabi, Jazz Pharmaceuticals, and Roche

SESSION TWO

How to Engage with Health Care Professionals (HCPs) Effectively

Presented by Sanavita Pharmaceuticals

Evening Socializing & Networking Reception in Exhibition Hall

Registration & Welcome Coffee in Exhibition Hall

SESSION ONE

Cell & Gene Therapy Forecasting

Presented by Lonza

Presented by Lonza

SESSION TWO

Marketing Pull-Through Mix

Presented by Bluebird Bio

SESSION ONE

Patient Empowerment through Technology: A Step towards a ‘Patient-Centric’ Future

The way to ideal healthcare and healthcare research is to be patient-centric, amalgamated with technology.

It is imperative to place patients first, in an open and sustained environment to respectfully and compassionately achieve the best outcome for them and their family. Unfortunately, communication between patients and the rest of the healthcare mechanism continues to be the missing link, which has so far prevented the former from being an active part of the conversation, the deliberation, the development, and the execution.
Our presentation elaborates on how the healthcare sector can overcome this problem opening a more direct and efficient line of a feedback system with patients through digital technology. The idea is to gather conscious and indirect patient inputs and digitally capture patient information (everything around authentic emotions, pain points, needs, unmet needs both on patient and caregiver side shortly after diagnosis, what their thoughts are when it comes to drug choices and therapy decisions) to better healthcare. This could enhance the ability of healthcare providers as well as researchers to address finer challenges and help pharma companies to make new approach based developments through an understanding of patients’ experiences and actual needs. Thus opening up new possibilities for the future of healthcare, including healthcare research that’s more patient-centric.

Presented by Borderless Access

SESSION TWO

TBA

SESSION ONE

Case Study- Translating Market Insights Into Action: Challenges & Solutions

Presented by Virbac S.A.

SESSION TWO

Democratization of Market Research

Presented by Ferring Pharmaceuticals

Networking & Refreshments in Exhibition Hall

“Ask the Experts” Interactive Breakout Round Tables Group 2

ROUND TABLE 1
AI: What Does It Mean for Market Research?

Presented by Abbott

ROUND TABLE 2
Deeper Dive: “The Status Quo, Challenges, Barriers and Potential Solutions: Are You a Traditional Market Research Provider or a Partner That Provides Your Company with Competitive Advantage”

Presented by Lonza

ROUND TABLE 3
Lessons Learned from Multi-Channel and Omni-Channel Marketing Strategies: What Is the Difference? Why Even Try? Which Minimum Organization, Tools and People Profiles Are Required? Examples of Failure and Success? Where to Start?

Presented by Fujirebio Europe

“Ask the Experts” Interactive Breakout Round Tables Group 3

ROUND TABLE 1
Using an Online Management System to Simplify the Conduct of Primary Market Research and Facilitate Insights Generation Across Teams and Countries

Presented by Amgen

ROUND TABLE 2
TBA

Presented by Takeda

ROUND TABLE 3
Identifying Market Needs and Offering Tailored Solutions: Start-Ups vs. Corporate World

• Mining consumer insights

• Keeping focus & being creative
• Engaging key opinion leaders

Key words: innovation, strategy, start-ups, consumer insights

A discussion on different approaches used by big corporations and start-ups when innovating: we´ll be able to make a comparison, discuss the best practices and learn from both perspectives.

Presented by Sanavita Pharmaceuticals

Networking Luncheon

Announcements

Summary & Key Takeaways

Presented by Actelion, Boehringer Ingelheim, GlaxoSmithKline, MSD, Teva Pharmaceuticals Europe, and UCB

Conference Concludes